Matsushima, Hisashi http://orcid.org/0000-0002-2567-8008
Taguchi, Tetsuya
Kodama, Sho
Okubo, Naoki
Saito, Kengo
Jabłońska, Katarzyna
Fukumoto, Seiji
Matsumoto, Toshio
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 30 May 2023
Accepted: 9 January 2024
First Online: 17 March 2024
Declarations
:
: HM has received consulting fees, speaking fees or honoraria from Daiichi Sankyo Co., Ltd. TT has received consulting fees from Daiichi Sankyo Co., Ltd., speaking fees from Pfizer and Asahi Kasei Pharma Corporation. SF has received consulting fees, speaking fees or honoraria from Daiichi Sankyo Co., Ltd. TM has received consulting fees, speaking fees or honoraria from Amgen Inc., Astellas Pharma Inc., Daiichi Sankyo Co., Ltd. and Chugai Pharmaceutical Co., Ltd. SK and NO and KS are employees of Daiichi Sankyo Co., Ltd., a pharmaceutical company which markets medications for the treatment of osteoporosis. KJ is an employee of Putnam PHMR, a consultancy company who received funding from Daiichi Sankyo Co., Ltd. for the implementation of this study.